Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.69 | N/A |
| PEG Ratio (TTM) | -2.24 | N/A |
| P/S Ratio (TTM) | 2.15 | N/A |
| P/B Ratio (TTM) | 2.71 | N/A |
| P/FCF Ratio (TTM) | 19.53 | N/A |
| Price to 5YR AVG Earnings Ratio | 23.04 | N/A |
| Price to 5YR AVG FCF Ratio | 33.06 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 8.72% | N/A |
| ROE (TTM) | 13.87% | N/A |
| Net Profit Margin (TTM) | 10.91% | N/A |
| ROIC 5YR AVG | 19.64% | N/A |
Growth (72%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -6.41% | 582.40% | 349.84% |
| Revenue | -1.58% | 20.75% | 7.96% |
| Net Income | -6.57% | 580.83% | 348.92% |
| Cash Flow | 69.77% | 338.27% | 964.44% |
Health (84%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.92 | N/A |
| Quick Ratio (TTM) | 2.69 | N/A |
| D/E Ratio (TTM) | 0.24 | N/A |
| Interest Coverage (TTM) | 23.69 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 5.80 | N/A |
| LTL to 5YR AVG FCF | 3.31 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.36% | N/A |